Purchase Order 75N93019P00948

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Becton, Dickinson and Company (BD Biosciences) valued at $13,237.18 on October 19, 2020. Place of performance is Bethesda, Maryland. The order is firm fixed price with no small business set-aside. Ultimate completion date is January 20, 2021. The source does not specify the equipment or supplies purchased under this order.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Becton, Dickinson And Company (BD Biosciences division) valued at $34,288.77 on June 3, 2019, with ultimate completion on June 20, 2020. Performance occurs in San Jose, California. The order is firm fixed price with no set-aside. The solicitation was posted May 17, 2019 and closed June 1, 2019.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Becton, Dickinson and Company, through its BD Biosciences division, for service contract work on laboratory equipment on April 1, 2023, with a ceiling value of $236,470.02. The order is firm fixed price with no set-aside applied. Performance takes place in North Bethesda, Maryland. The ultimate completion date is March 31, 2024.</p>

The National Institute of Allergy and Infectious Diseases awarded a purchase order to Becton, Dickinson and Company for $362,388.00 on February 2, 2015, with ultimate completion on March 31, 2020. No small business set-aside was used. The order is firm fixed price. Place of performance is Bethesda, Maryland. The awardee, operating as BD Biosciences, supplies flow cytometry systems, laboratory instrumentation, reagents, and associated consumables and technical support services to federal...

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Becton, Dickinson And Company's BD Biosciences division valued at $124,560.00 on March 27, 2015, with ultimate completion on February 22, 2020. The order covers maintenance of laboratory equipment and instrumentation at the agency's Bethesda, Maryland facility. No set-aside was used. The contract employed firm fixed pricing for the maintenance work supporting government-owned analytical systems.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Becton, Dickinson and Company for BD cytometers and lasers valued at $34,936.89 on April 16, 2018, with completion on January 20, 2019. Performance occurs in Bethesda, Maryland. The order is firm fixed price with no set-aside applied.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Becton, Dickinson And Company valued at $153,971.76 on February 12, 2018, for service contract work on various BD cytometers and lasers. Performance is located in North Bethesda, Maryland, with an ultimate completion date of January 20, 2019. The contract carries firm fixed-price pricing and no set-aside designation.</p>

The National Institute of Allergy and Infectious Diseases awarded a purchase order to Becton, Dickinson and Company (BD Biosciences division) valued at $497,331.25 on August 13, 2018, for maintenance of BD equipment. Performance is located in Franklin Lakes, New Jersey. The order covers maintenance services for BD-manufactured biomedical research instruments and diagnostic equipment. The ultimate completion date is September 14, 2018. Pricing is firm fixed price with no small business...

The National Institute of Allergy and Infectious Diseases awarded a purchase order to Becton, Dickinson and Company for $68,892.18 on January 17, 2019, for service on BD LSR II flow cytometers and lasers, covering both base year and option year 1 periods with a ceiling value matching the award amount and ultimate completion date of September 30, 2020. Performance takes place in North Bethesda, Maryland. The order is firm fixed price with no small business set-aside. The originating...

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Becton, Dickinson And Company (BD Biosciences division) on August 28, 2018, with a ceiling value of $679,200.22 for firm fixed price delivery. Place of performance is San Jose, California. The order's ultimate completion date is September 21, 2018. The contract designation is BD LSRFORTESSA with no set-aside category applied.</p>